(Total Views: 455)
Posted On: 10/13/2020 9:41:06 AM
Post# of 36519
Well written press release. This is what I was talking about last night. I believe if Herceptin wasn’t added there would have been benefit seen in her2 high expressors. I thought that a peer review on the trial from a few years ago showed dfs not much different between AE37 and Herceptin in that 3+ group. That doesn’t show a statistically significant difference obviously, but Herceptin is basically a cure. But AE37 is safer. You could probably never design a study unless equivalence. Anyway, great press release. I appreciate their expert description in helping to understand that report.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)